Dr. Robert Scott Hamilton, MD

Dr. Hamilton practices at OSF Multi-Specialty Group in Normal, Illinois.

Dr. Hamilton's NPI, 1164431904, was assigned on August 7, 2006. Dr. Hamilton holds Illinois license 36077853.

Dr. Hamilton's primary practice is OSF Multi-Specialty Group, at 2200 Ft Jesse Rd, Normal, IL 61761 in Mclean County. The practice phone is (309) 683-5050.

Dr. Hamilton's primary practice is OSF Multi-Specialty Group in Normal, Illinois. Dr. Hamilton is also affiliated with OSF St. Joseph Medical Center. The medical group on file is OSF Multi-Specialty Group. Dmand AI also links Dr. Hamilton to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hamilton practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Hamilton's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Hamilton is licensed in Illinois.

CMS data shows 312 Medicare services from Dr. Hamilton across 2 procedure codes in 2024, all of them office visits, for 146 Medicare patients. Medicare paid $24,600 for them. Every service was in an office.

CMS counts 146 Medicare patients who saw Dr. Hamilton in 2024. The largest group is 65 to 74, with 69 patients. 75% of them have anxiety, and 75% have mood disorders. 27% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hamilton's median patient age at 56, with 69% women.

In 2024, Dr. Hamilton wrote 5,908 Medicare Part D claims for 432 patients. 89% of them were for generic drugs. CMS names the drug for 5,708 of them, across 72 drugs with 11 or more claims each, at $1,436,015 in total drug cost. In 2023, CMS named 6,927 claims across 78 drugs.

Dr. Hamilton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hamilton as offering telehealth.

CMS Open Payments shows 191 general payments to Dr. Hamilton from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 59% of the total. Axsome Therapeutics, Inc. paid the most, $40,395.